During the last three decades there has been a dramatic increase in the frequency of fungal infections in immunocompromised patients1~3).
Deep-seated mycoses are increasingly observed in patients undergoing organ transplants and in patients receiving aggressive cancer chemotherapy4\
For example, the incidence of fungal infections following solid organ transplantation ranges from 5% in kidney recipients, between 15 and 35% in lung and heart recipients, and up to 40%in liver recipients4). The most commonpathogens associated with invasive fungal itraconazole and fluconazole) that inhibit membrane-sterol biosynthesis4'9^Even though amphotericin B has a broad range of activity and is viewed as the "gold standard" of antifungal therapy, its use is limited due to infusion-related reactions and nephrotoxicity4?6). Flucytosine use is also limited due to the development of resistance and its narrow spectrum of activity while the wide-spread use of azoles is causing the emergence of clinically-resistant strains of Candida spp4 '10 Some of the oldest life-forms on Earth that withstand and even thrive in unusual ecosystems are known as "extremophiles". The unique genomes of these organisms are believed to have been adapted initially to suit the extreme environments that the earliest organisms on this planet faced. Today these organisms live in habitats that will support no other form of life. Most thermophilic extremophiles are moderate and grow at temperatures above 45°C17'18); they are still able to grow but slowly between 25°C and 40°C18). Research on thermophiles has been on-going for several decades with the most noted being the discovery of heat-stable DNApolymerase used in the polymerase chain reaction19). More recent work has been focused on other unusual ecosystems where extremophiles have been isolated from waters above 100°C in terrestrial hot springs and deep-sea thermal vents, at temperatures below 0°C in arctic waters, at immense pressure under several miles of water on the ocean floor, in the saturated salt environment of the Great Salt Lake, at very high osmolarities (e.g., high sugar concentrations), at pHvalues less than pH 2 in drainage in certain mines and geothermal sulfur-rich springs, at pHvalues greater than pH ll, and in media containing toxic compounds20). The research thus far has focused on the isolation of "extremozymes" that might provide novel opportunities for biocatalysis in research and in industrial chemical processing20 ' 2 1Â s far as we are aware, there are no reports of screening extremophiles for antifungal activity. Each extremophile was grown to stationary phase in 500 ml mediumin one liter mini-fermentors with individually controlled air flow using a two port system (air inlet and outlet) at air flows of 250 to 1000 ml air/minute. In general, microorganismswere incubated in the mediumon whichan organism was originally isolated. Media were adjusted to the pH approximating that of the original habitat. A loopful of cells from a storage slant was used to inoculate each mini-fermentor. Incubations were performed at the temperature of the original habitat. In general, organisms grown at 45°C or above were incubated for three days, while those at less than 45°C were incubated for four to seven days. Organism 8(C)X was isolated from Beach Springs Lake, Wyoming; the pH of the lake was pH 6.7
while the ambient water temperature was~20°C.
Analysis of 16S rDNA
Organism 8(C)X was harvested and genomic DNA isolated. The 16S rRNAencoding gene was PCR-amplified from genomic DNA.Primers used for the amplification Uninoculated media were processed in the same manner. Ethanol extract: The biomass from each fermentation wastransferred to a 50-ml disposable centrifuge tube and brought to a final volume of 40ml with absolute ethanol. Tubes were shaken for 10 minutes and then centrifuged JAN. 2001 (1700#) for 30 minutes. The ethanolic supernatants were decanted into 40-ml glass vials, the extracted biomasses discarded, and each solution reduced to~2ml under a stream of dry air at 27°C. The concentrated samples were transferred to pre-weighed screw top glass tubes (16X100mm) and taken to dryness in vacuo at ambient temperature in a SpeedVac concentrator. The weight of each ethanolic extract was determined, the extracts dissolved in one ml 50% (v/v) aqueous methanol and 500 ji\ of each sample dispensed into individual wells of deep 96-well plates. The plates were placed into a SpeedVac concentrator and the samples reduced to dryness. was measured using lysates from A. fumigatus as enzyme sources as described by Selitrennikoff and Ostroff30).
The inhibitor, 6-diazo-5-oxo-norleucine, was used as a control for enzyme inhibition and had an IC50 of 17 ng/ml (-0.1 jUM). The amounts of protein in cell extracts were determined using the Bio-Rad kit following the manufacturer's directions.
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Fractionation of Organism 8(C)X To identify the active compoundpresent in the extract from 8(C)X, the organism was grown at 25°C in 80 500-ml fermentors as described above and the medium was extracted three times with EtOAc (-40 liters, total). The combined organic extracts were evaporated in vacuo to dryness (-1.5g). The extract was separated using automated preparative reversed-phase HPLC and solid phase extraction (described in the next section) and 40-ml fractions collected. Oneml aliquots of each fraction were taken to dryness in vacuo, re-suspended in DMSO(10jiX) and tested for antifungal activity using the C. albicans whole cell assay. Two active fractions were further separated by HPLC and three resulting active fractions analyzed by NMR. were screened for antifungal activity. Twenty-nine broth extracts (1 3%of total) and each of the antifungal-producing control organisms had activity against C. albicans (results not shown). To confirm these observations, a second fermentation of these 29 microorganisms and the five antifungal-producing organisms was prepared and an ethyl acetate extract madefrom the spent broth as well as an ethanolic extract of each biomass. As expected, each extract of the fermentation broth and/or biomass of the five antifungal-producing organisms had antifungal activity in both the whole-cell and the protoplast-regeneration assays (Table 1) . Of the 29 microorganisms re-tested, the ethyl acetate extracts of only 15 were active against C. albicans (Table 1 ). The remaining 14 microorganisms failed to reproduce the original activity for reason(s) not understood (results not shown). None of the biomass extracts was active in the C. albicans whole-cell agar diffusion assay while seven were active against protoplasts ( Table 1) . The ethyl acetate extracts of the fermentation broths from the 15 active microorganisms were tested against a polyene-resistant strain of C. albicans as described in the Materials and Methods. The broth extracts of four organisms were not active (not shown); none of these four organisms was considered further. Extracts of the fermentation broths of the eleven remaining microorganisms (and the five control antifungal-producing organisms) were tested further to determine their breadth of activity and to elucidate possible mechanisms of antifungal activity. These results are presented in Table 2 . Again as expected, each of the five control organisms was active. Note that extracts of four microorganismswere also active against C. glabrata, showing that these extracts had broad anti-candidal activity. Importantly, the ethyl acetate extracts ofbroths from 8(C)X, 430 PER and 197 PER were active against A. fumigatus, C. glabrata and wild-type C. albicans.
In an effort to ascribe a mechanismof action to the antifungal compounds in each extract, we tested broth extracts from each of the eleven active microorganisms for inhibition of chitin synthase, (l,3)/3-glucan synthase and ketol-isomerase activities (each activity is essential for fungal cell-wall formation) as described in the Materials and Methods. These results are summarized in Table 3 . Based on the observation that the extract from organism 8(C)X had broad antifungal activity against C. albicans, polyene-resistant C. albicans, C. glabrata, and A. fumigatus, we decided to identify the active component (s) present in this extract. Previously, we had determined that organism 8(C)X grew between pH 4 and pH 9, and had a Tmax of~50°C (unpublished results). Importantly, the 16s rDNA nucleotide sequence from organism 8(C)X was similar but not identical to Pseudomonas veronii (not shown), indicating that organism 8(C)X is a novel species of Pseudomonas. Details of the species identification of this and other antifungal producing microorganisms will be presented elsewhere (Selitrennikoff, et ah, in preparation).
Second, we pooled the broths from 80 500-ml The fermentation broths of 80 500-ml cultures of P. akbaalia were grown, harvested and extracted with ethyl acetate as described in the Materials and Methods. assayed for antifungal activity using the C. albicans wholecell assay described in the Methods. Fractions K and L were the only fractions with antifungal activity (results not shown). Fractions K and L were further separated as described in the Methodsand these results are shownin Figure 3A for Fraction K and Figure 3B for Fraction L. Each fraction was tested for antifungal activity using the C. albicans whole cell assay and fractions K7, K8, and L7 were the only fractions with activity (not shown). Each of these fractions (i.e., K7, K8 and L7) was subjected to MS and NMRanalysis as described in the Methods in order to determine the structure of the active compound. In each case, the MSand NMRpatterns were consistent to that of pyochelin and pyochelin derivatives (not shown). The structure of pyochelin is shown in Figure 4 . To confirm that the antifungal activity was indeed due to pyochelin, we obtained bona fide pyochelin from Dr. C. Cox (University We chose to examine one organism in detail and determined that organism 8(C)X is a novel species of Pseudomonas (based on 16S rDNAsequence comparisons).
We have named this species Pseudomonas akbaalia. Importantly, we have identified an active componentof the extract of the fermentation broth of Pseudomonasakbaalia as pyochelin, an iron-binding compound. Authentic pyochelin was also antifungal, confirming that pyochelin is in part responsible for the antifungal activity observed in the extract of the fermentation broth. Whether other active compoundsare also present is not knownat this time. Taken together, our results indicate that at least ll microorganisms warrant further investigation in order to identify the biologically active compoundspresent in the extracts. Importantly, the work presented in this manuscript points to extremophiles as an unexplored source of novel These extracts are currently being fractionated to isolate and identify the active compound(s). These results will be the subject of future manuscripts elucidating the biological activities and structures of the active compounds.
